EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
Identificadores
URI: http://hdl.handle.net/20.500.12020/1253ISSN: 1198-743X
DOI: 10.1016/j.cmi.2016.01.017
Autor/es
Arendrup, Maiken; Meletiadis, Joseph; Mouton, Johan; Guinea, Jesus; Cuenca-Estrella, Manuel; [et al.]Fecha
2016-06-01Tipo de documento
articleÁrea/s de conocimiento
Ciencias BiomédicasMateria/s Unesco
3201.03 Microbiología ClínicaResumen
The Subcommittee on Antifungal Susceptibility Testing (AFST) of
the ESCMID European Committee for Antimicrobial
Susceptibility Testing (EUCAST) has determined breakpoints for
isavuconazole and Aspergillus and for itraconazole and Candida
spp., released a new document summarizing existing and new
minimum inhibitory concentration ranges for quality control
strains and revised the method documents for yeast and mould
susceptibility testing. This technical note is based on the EUCAST
isavuconazole and itraconazole rationale documents, version 1.0
of the routine and extended internal quality control for antifungal
susceptibility testing as recommended by EUCAST, and the E.Def
7.3, E.Def 9.2 and E.Def 9.3 method documents (http://www.
eucast.org).